Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hetlioz
Pharma
Supreme Court rejects Vanda's Hetlioz patent revival appeal
The U.S. Supreme Court has rebuffed Vanda's bid to revive patents on its 10-year-old sleep disorder drug Hetlioz following a 2023 appeals court loss.
Fraiser Kansteiner
Apr 22, 2024 3:49pm
15 years later, Vanda secures another FDA nod for Fanapt
Apr 3, 2024 11:04am
Vanda scores courtroom win over FDA in records case
Mar 29, 2023 3:15pm
Teva, Apotex prevail over Vanda in patent infringement case
Dec 14, 2022 2:11pm
OPDP ramp-up spawns new letter warning Vanda for omitted risks
Nov 1, 2018 10:59am
Aka-what? Vanda puts spotlight on antipsychotic side effect
Aug 14, 2017 9:32am